| RS869320648 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS869320649 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS869320651 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS869320652 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS869320653 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS869320654 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS869320655 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS869320656 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS869320657 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS869320658 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, Combined immunodeficiency |
| RS869320659 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, Combined immunodeficiency |
| RS869320660 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS869320661 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, ATP1A3-related disorder |
| RS869320664 |
TIMM8A
|
Health Risk |
Pathogenic |
Deafness dystonia syndrome, Deafness dystonia syndrome |
| RS869320665 |
TIMM8A
|
Health Risk |
Pathogenic |
Deafness dystonia syndrome, Deafness dystonia syndrome |
| RS869320666 |
TIMM8A
|
Health Risk |
Pathogenic |
Deafness dystonia syndrome, Deafness dystonia syndrome |
| RS869320667 |
TIMM8A
|
Health Risk |
Pathogenic |
Deafness dystonia syndrome, Deafness dystonia syndrome |
| RS869320668 |
GATA2
|
Health Risk |
Likely pathogenic |
Monocytopenia with susceptibility to infections, Deafness-lymphedema-leukemia syndrome |
| RS869320671 |
LAMB3
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1A, Amelogenesis imperfecta type 1A |
| RS869320672 |
ALDH6A1
|
Health Risk |
Pathogenic |
Methylmalonate semialdehyde dehydrogenase deficiency, Methylmalonate semialdehyde dehydrogenase deficiency |
| RS869320673 |
APPL1
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 14, Maturity-onset diabetes of the young type 14 |
| RS869320674 |
WHRN
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 31, Autosomal recessive nonsyndromic hearing loss 31 |
| RS869320675 |
MYT1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS869320676 |
MYT1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS869320677 |
XRCC4
|
Health Risk |
Pathogenic/Likely pathogenic |
Short stature, microcephaly |
| RS869320678 |
XRCC4
|
Health Risk |
Pathogenic |
Short stature, microcephaly |
| RS869320679 |
TBX18
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital anomalies of kidney and urinary tract 2, Congenital anomaly of kidney and urinary tract |
| RS869320680 |
DAG1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 |
| RS869320681 |
DDX3X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 102 |
| RS869320682 |
CUL4B
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked intellectual disability Cabezas type, CUL4B-related disorder |
| RS869320683 |
RSPH4A
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 11, Kartagener syndrome |
| RS869320684 |
FANCL
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group L, VATER association |
| RS869320685 |
FANCL
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group L, VACTERL association |
| RS869320686 |
LZTR1
|
Health Risk |
Likely pathogenic |
Noonan syndrome 10, LZTR1-related schwannomatosis |
| RS869320687 |
SOS2
|
Health Risk |
Likely pathogenic |
Noonan syndrome 9, Noonan syndrome |
| RS869320688 |
NFKB1
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS869320689 |
NFKB1
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS869320690 |
ALDH18A1
|
Health Risk |
Pathogenic |
Autosomal recessive complex spastic paraplegia type 9B, Autosomal recessive complex spastic paraplegia type 9B |
| RS869320691 |
PPP2R5D
|
Health Risk |
Pathogenic/Likely pathogenic |
Hogue-Janssens syndrome 1, Hogue-Janssens syndrome 1 |
| RS869320692 |
SLC9A3
|
Health Risk |
Pathogenic |
Congenital secretory sodium diarrhea 8, Congenital secretory sodium diarrhea 8 |
| RS869320693 |
TANGO2
|
Health Risk |
Pathogenic/Likely pathogenic |
Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome, Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome |
| RS869320694 |
FGFR1
|
Health Risk |
Pathogenic |
Encephalocraniocutaneous lipomatosis, Pilomyxoid astrocytoma |
| RS869320695 |
NUP93
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 12 |
| RS869320696 |
CTNNA1
|
Health Risk |
Pathogenic |
Patterned macular dystrophy 2, Patterned macular dystrophy 2 |
| RS869320697 |
CTNNA1
|
Health Risk |
Pathogenic |
Patterned macular dystrophy 2, Patterned macular dystrophy 2 |
| RS869320698 |
GBE1
|
Health Risk |
Likely pathogenic |
Adult polyglucosan body neuropathy, Adult polyglucosan body disease |
| RS869320700 |
DNAJB6
|
Health Risk |
Pathogenic |
Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6), Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) |
| RS869320701 |
DNAJB6
|
Health Risk |
Pathogenic |
Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6), Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) |
| RS869320702 |
DNAJB6
|
Health Risk |
Pathogenic |
Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6), Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) |
| RS869320703 |
GFM2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation deficiency 39, Combined oxidative phosphorylation deficiency 39 |
| RS869320704 |
GFM2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation deficiency 39, Combined oxidative phosphorylation deficiency 39 |
| RS869320705 |
RPS6KA3
|
Health Risk |
Pathogenic |
Coffin-Lowry syndrome, Intellectual disability |
| RS869320706 |
MET
|
Health Risk |
risk factor |
Osteofibrous dysplasia, Osteofibrous dysplasia |
| RS869320708 |
TMLHE
|
Health Risk |
risk factor |
Epsilon-trimethyllysine hydroxylase deficiency, Epsilon-trimethyllysine hydroxylase deficiency |
| RS869320709 |
GUCA1A;GUCA1ANB-GUCA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone dystrophy 3, Retinal dystrophy |
| RS869320710 |
GUCA1ANB-GUCA1A;GUCA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone dystrophy 3, Cone-rod dystrophy 14 |
| RS869320712 |
WDR73
|
Health Risk |
Conflicting classifications of pathogenicity |
Galloway-Mowat syndrome 1, WDR73-related disorder |
| RS869320713 |
ZMYND11
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS869320714 |
SLFN14
|
Health Risk |
Pathogenic/Likely pathogenic |
Platelet-type bleeding disorder 20, Thrombocytopenia |
| RS869320715 |
SLFN14
|
Health Risk |
Conflicting classifications of pathogenicity |
Platelet-type bleeding disorder 20, Abnormal bleeding |
| RS869320716 |
SLFN14
|
Health Risk |
Likely pathogenic |
Platelet-type bleeding disorder 20, Inborn genetic diseases |
| RS869320717 |
ALX4
|
Health Risk |
Pathogenic |
Frontonasal dysplasia with alopecia and genital anomaly, Frontonasal dysplasia with alopecia and genital anomaly |
| RS869320719 |
SLC25A38
|
Health Risk |
Pathogenic/Likely pathogenic |
Sideroblastic anemia 2, SLC25A38-related disorder |
| RS869320720 |
SLC4A11
|
Health Risk |
Pathogenic |
Congenital hereditary endothelial dystrophy of cornea, Congenital hereditary endothelial dystrophy of cornea |
| RS869320721 |
SLC4A11
|
Health Risk |
Pathogenic/Likely pathogenic |
Corneal dystrophy-perceptive deafness syndrome, Congenital hereditary endothelial dystrophy of cornea |
| RS869320722 |
SLC4A11
|
Health Risk |
Pathogenic |
Corneal dystrophy-perceptive deafness syndrome, Corneal dystrophy-perceptive deafness syndrome |
| RS869320723 |
GLIS3
|
Health Risk |
Pathogenic |
Neonatal diabetes mellitus with congenital hypothyroidism, Neonatal diabetes mellitus with congenital hypothyroidism |
| RS869320724 |
TMPRSS6
|
Health Risk |
Pathogenic |
Iron-refractory iron deficiency anemia, Iron-refractory iron deficiency anemia |
| RS869320725 |
SIL1
|
Health Risk |
Pathogenic |
Marinesco-Sjögren syndrome, Marinesco-Sjögren syndrome |
| RS869320726 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 1, Retinitis pigmentosa |
| RS869320727 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 1, Retinitis pigmentosa 1 |
| RS869320728 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 1, Retinitis pigmentosa 1 |
| RS869320729 |
CASR
|
Health Risk |
Pathogenic |
Neonatal severe primary hyperparathyroidism, Neonatal severe primary hyperparathyroidism |
| RS869320730 |
COMP
|
Health Risk |
Pathogenic |
Multiple epiphyseal dysplasia type 1, Multiple epiphyseal dysplasia type 1 |
| RS869320731 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS869320732 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS869320733 |
TIMM8A
|
Health Risk |
Pathogenic |
Deafness dystonia syndrome, Deafness dystonia syndrome |
| RS869320734 |
GATA2
|
Health Risk |
Likely pathogenic |
Monocytopenia with susceptibility to infections, GATA2 deficiency with susceptibility to MDS/AML |
| RS869320735 |
GATA2
|
Health Risk |
Pathogenic |
Monocytopenia with susceptibility to infections, GATA2 deficiency with susceptibility to MDS/AML |
| RS869320736 |
SRD5A3
|
Health Risk |
Pathogenic |
Kahrizi syndrome, Kahrizi syndrome |
| RS869320737 |
BOLA3
|
Health Risk |
Pathogenic |
Multiple mitochondrial dysfunctions syndrome 2, Multiple mitochondrial dysfunctions syndrome 2 |
| RS869320738 |
PNPLA2
|
Health Risk |
Pathogenic |
Neutral lipid storage myopathy, Neutral lipid storage myopathy |
| RS869320739 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, myofibrillar |
| RS869320740 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Myopathy, myofibrillar |
| RS869320741 |
TTN
|
Health Risk |
Pathogenic |
Myopathy, myofibrillar |
| RS869320742 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Myopathy, myofibrillar |
| RS869320743 |
TTN
|
Health Risk |
Pathogenic |
Myopathy, myofibrillar |
| RS869320744 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS869320745 |
TYK2
|
Health Risk |
Pathogenic |
Immunodeficiency 35, Immunodeficiency 35 |
| RS869320746 |
GTPBP3
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 23, Combined oxidative phosphorylation defect type 23 |
| RS869320748 |
SNX14
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 20, Autosomal recessive spinocerebellar ataxia 20 |
| RS869320750 |
TWIST2
|
Health Risk |
Pathogenic |
Barber-Say syndrome, Barber-Say syndrome |
| RS869320751 |
ATF6
|
Health Risk |
Pathogenic |
Achromatopsia 7, Achromatopsia 7 |
| RS869320752 |
FKBP10
|
Health Risk |
Pathogenic |
Bruck syndrome 1, Osteogenesis imperfecta |
| RS869320753 |
MCM8
|
Health Risk |
Pathogenic |
Premature ovarian failure 10, Premature ovarian failure 10 |
| RS869320754 |
NFKB1
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS869320755 |
PPP2R5C
|
Health Risk |
Pathogenic |
— |
| RS869320757 |
GLRX5
|
Health Risk |
Likely pathogenic |
Spasticity-ataxia-gait anomalies syndrome, Spasticity-ataxia-gait anomalies syndrome |
| RS869320758 |
GLRX5
|
Health Risk |
Pathogenic |
Spasticity-ataxia-gait anomalies syndrome, Spasticity-ataxia-gait anomalies syndrome |
| RS869320759 |
SLC9A3
|
Health Risk |
Pathogenic |
Congenital secretory sodium diarrhea 8, Congenital secretory sodium diarrhea 8 |